NCT02143466 2026-01-30AZD9291 in Combination With Ascending Doses of Novel TherapeuticsAstraZenecaPhase 1 Active not recruiting344 enrolled
NCT05777603 2026-01-12Study of Aerosolized Antibiotics and Pembrolizumab in Advanced Non-small Cell Lung CancerNational Institutes of Health Clinical Center (CC)Phase 1 Recruiting23 enrolled